News & Updates
Filter by Specialty:
Continued anti-VEGF use after disease control does not prevent nAMD recurrence
06 Apr 2022
In patients with neovascular age-related macular degeneration (nAMD) who achieve functional and morphological disease stability, continuing treatment with antivascular endothelial growth factors (anti-VEGF) does not substantially reduce the risk of recurrence, reports a recent study.
Continued anti-VEGF use after disease control does not prevent nAMD recurrence
06 Apr 2022Do outpatient ophthalmologic procedures increase risk for acute MI?
29 Mar 2022
Ophthalmologic procedures performed in an outpatient setting do not seem to heighten the risk for acute myocardial infarction (AMI), a study has shown.